NIH List Ivermectin as COVID Cure without Notifying

U.S. National Institutes of Health (NIH) quietly put Ivermectin on the Covid-19 Treatment Guidelines for the first time, alongside Remdesivir and Paxlovid. NIH states that “the Panel recommends against the use of Ivermectin for the treatment of COVID-19, except in clinical trials.” It is said the negative description of Ivermectin is because that NIH needs to be compliant with the previous Emergency Use Authorization for Vaccines.

Legislators from several States proposed bills to make ivermectin more convenient to treat Covid cases. Tennessee and New Hampshire have passed bills months ago to list Ivermectin as over-the-counter drug. The shift of NIH may relate to Fauci‘s departure from the positions as Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the end of December, and to the unavoidable vaccine disaster.

Aussie Brief News
Aussie Brief News

Go to First Page and Get the Latest News.

Translator: MOS Health Team
Design&editor: HBamboo(昆仑竹)

Leave a Reply

Your email address will not be published. Required fields are marked *